END STAGE RENAL DISEASE

This adverse event was reported 13820 times

These drugs are most commonly taken by patients reporting END STAGE RENAL DISEASE:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 9017
1 ESOMEPRAZOLE MAGNESIUM 8944
2 LANSOPRAZOLE 8588
3 ESOMEPRAZOLE SODIUM 8558
4 PANTOPRAZOLE SODIUM 6571
5 DEXLANSOPRAZOLE 4477
6 OMEPRAZOLE 2942
7 FUROSEMIDE 2514
8 PANTOPRAZOLE 2161
9 LISINOPRIL 2156
See all common drugs associated with END STAGE RENAL DISEASE

END STAGE RENAL DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE 221 0.1720
1 DEXLANSOPRAZOLE 4477 0.1402
2 LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN 45 0.1210
3 BISMUTH SUBSALICYLATE 388 0.0989
4 COPANLISIB 18 0.0984
5 CIMETIDINE HYDROCHLORIDE 9 0.0909
6 CALCIUM ACETATE CAPSULES 667 MG 319 0.0814
7 OMEPRAZOLE AND SODIUM BICARBONATE 189 0.0777
8 PANTOPRAZOLE SODIUM 6571 0.0713
9 LANSOPRAZOLE 8588 0.0663
See all drugs enriched for association with END STAGE RENAL DISEASE

END STAGE RENAL DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bismuth [EPC] 388 0.0989
1 Vitamin D2 Analog [EPC] 66 0.0517
2 Anti-coagulant [EPC] 225 0.0450
3 alpha-Hydroxy Acid [EPC] 29 0.0307
4 Antihypoglycemic Agent [EPC] 52 0.0262
5 Proton Pump Inhibitor [EPC] 9401 0.0244
6 Central alpha-2 Adrenergic Agonist [EPC] 896 0.0234
7 Non-narcotic Antitussive [EPC] 270 0.0229
8 Cephalosporin Antibacterial [EPC] 113 0.0214
9 Vitamin D3 Analog [EPC] 619 0.0211
See all drug classes enriched for association with END STAGE RENAL DISEASE